Ticker > Company >

Fortis Healthcare share price

Fortis Healthcare Ltd.

NSE: FORTIS BSE: 532843 SECTOR: Hospital & Healthcare Services  197k   634   134

754.50
-4.60 (-0.61%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 756.25

Today's Low

₹ 742.45

52 Week High

₹ 786.3

52 Week Low

₹ 452.75

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

56961.59 Cr.

Enterprise Value

57157.25 Cr.

No. of Shares

75.5 Cr.

P/E

893.01

P/B

6.28

Face Value

₹ 10

Div. Yield

0.13 %

Book Value (TTM)

₹  120.19

CASH

119.95 Cr.

DEBT

315.61 Cr.

Promoter Holding

31.17 %

EPS (TTM)

₹  0.84

Sales Growth

12.2%

ROE

2.21 %

ROCE

3.51%

Profit Growth

107.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Fortis Healthcare Ltd.

SRL La-femme

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year12.2%
3 Year23.13%
5 Year12.47%

Profit Growth

1 Year107.25%
3 Year262.2%
5 Year10.14%

ROE%

1 Year2.21%
3 Year1.05%
5 Year1.83%

ROCE %

1 Year3.51%
3 Year2.35%
5 Year3.36%

Debt/Equity

0.0347

Price to Cash Flow

260.76

Interest Cover Ratio

4.0099

CFO/PAT (5 Yr. Avg.)

0.781509177396328

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 31.17 0.00
Dec 2024 31.17 0.00
Sep 2024 31.17 0.00
Jun 2024 31.17 0.00
Mar 2024 31.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 23.1294481927558% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -508.7793 days.

 Limitations

  • Company has a poor ROE of 1.04666608739539% over the past 3 years.
  • Company has a poor ROCE of 2.34913685915097% over the past 3 years
  • The company is trading at a high PE of 893.01.
  • The company is trading at a high EV/EBITDA of 129.2577.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 307.48 333.4 357.15 366.87 388.47
Total Expenditure 238.18 275.46 297.3 300.11 317.51
Operating Profit 69.3 57.94 59.85 66.76 70.96
Other Income 32.5 35.43 104.17 33.96 24.99
Interest 18.44 16.84 16.32 26.51 51.91
Depreciation 25.85 26.03 27.41 28.96 30.52
Exceptional Items 32.1 0 -68.28 5.56 -52.42
Profit Before Tax 89.61 50.5 52.01 50.81 -38.9
Tax 21.28 23.67 12.38 11.25 3.33
Profit After Tax 68.33 26.83 39.63 39.56 -42.23
Adjusted EPS (Rs) 0.91 0.36 0.52 0.52 -0.56

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 701.85 632.87 862.61 1052.93 1181.42
Total Expenditure 633.91 604.96 747.21 919.78 988.62
Operating Profit 67.94 27.91 115.41 133.15 192.81
Other Income 938.34 191.98 134.09 149.58 143
Interest 160.17 141.45 129.58 106.24 81.92
Depreciation 96.81 110.77 112.63 115.88 100.98
Exceptional Items -128.63 56.46 -16.28 48.29 93.65
Profit Before Tax 620.68 24.13 -8.99 108.88 246.56
Tax 107.35 19.93 4.26 12.64 47.11
Net Profit 513.33 4.2 -13.25 96.24 199.45
Adjusted EPS (Rs.) 6.8 0.06 -0.18 1.27 2.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 754.96 754.96 754.96 754.96 754.96
Total Reserves 8121.51 8126.57 8113.61 8208.58 8332.21
Borrowings 621.35 663.78 585.52 281.58 254.05
Other N/C liabilities 763.69 732.48 682.92 556.38 522.29
Current liabilities 468.51 472.51 462.74 644.66 760.13
Total Liabilities 10730.02 10750.31 10599.75 10558.48 10623.65
Assets
Net Block 906.2 852.83 770.28 491.86 467.31
Capital WIP 29.18 6.32 6.33 2.67 259.38
Intangible WIP 3.64 0.42 0 0 0.82
Investments 8153.11 8898.47 8845.29 8847.6 8834.04
Loans & Advances 1277.61 605.51 570.78 525.56 420.23
Other N/C Assets 1.55 1.31 1.38 256.36 0.37
Current Assets 358.72 385.44 405.69 434.42 641.5
Total Assets 10730.02 10750.31 10599.75 10558.48 10623.65
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 620.68 24.13 -8.99 108.88 246.56
Adjustment -553.21 24.6 123.55 27.6 -46.82
Changes in Assets & Liabilities 43.52 -7.28 10.72 95.53 41.77
Tax Paid -11.07 -9.5 -48.79 -33.64 -23.06
Operating Cash Flow 99.92 31.94 76.49 198.38 218.45
Investing Cash Flow 810.04 28.4 237.74 204.62 44.46
Financing Cash Flow -971.53 5.91 -319.83 -395.43 -245.35
Net Cash Flow -61.57 66.26 -5.6 7.57 17.56

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 31.17 31.17 31.17 31.17 31.17
northern tk venture pte. ... - - - - 31.17
northern tk venture pte.l... 31.17 - - 31.17 -
northern tk venture pte. ... - - 31.17 - -
northern tk venture pte l... - 31.17 - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 68.83 68.83 68.83 68.83 68.83
aditya birla sun life tru... 3.93 3.64 3.47 2.97 2.46
amansa holdings private l... 1.39 1.39 1.41 1.41 1.70
axis bank limited 1.19 1.19 1.19 1.19 1.19
axis mutual fund trustee ... 2.66 3.15 3.29 3.46 3.40
dsp equity opportunities ... - - - - 1.29
fidelity funds - india fo... - - 1.67 - 1.62
hdfc mutual fund - hdfc s... - - - 5.86 6.00
jupiter india fund 1.75 1.85 1.86 1.81 1.52
kotak emerging equity sch... - - - - 4.56
kotak funds - india midca... 1.32 1.25 1.28 - 1.24
mirae asset nifty midcap ... - - 1.77 - 1.33
nippon life india trustee... - - 2.37 - 2.28
rekha jhunjhunwala 4.07 4.21 4.07 4.07 4.07
sbi life insurance co. lt... 2.43 - - - 1.53
fidelity funds-india focu... 1.67 1.67 - 1.72 -
government pension fund g... - - 1.23 1.14 -
kotak funds-india midcap ... - - - 1.27 -
kotak mahindra trustee co... - - - 4.40 -
mire asset elss tax saver... - - - 1.54 -
nippon life india trustee... - - - 2.40 -
sbi life insurance co.ltd... - 2.47 1.42 1.40 -
sbi long term equity fund... - - 1.11 1.15 -
hdfc mutual fund - hdfc n... - - 5.56 - -
kotak mahindra trustee co... - - 5.28 - -
sundaram mutual fund a/c ... - - 1.13 - -
hdfc mutual fund - hdfc b... - 5.19 - - -
kotak mahindra trustee co... - 4.47 - - -
mirae asset midcap fund - 2.99 - - -
nippon india trustee ltd-... - 2.43 - - -
sbi large & midcap fund - 1.49 - - -
sundaram mutual fund a/c ... - 1.23 - - -
hdfc large and mid cap fu... 4.92 - - - -
kotak focused equity fund... 2.15 - - - -
mirae asset large & midca... 3.67 - - - -
nippon life india trustee... 2.46 - - - -
sbi nifty midcap 150 inde... 2.19 - - - -
sundaram mutual fund a/c ... 1.39 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CARE
TYPE AGENCY ACTION
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Ventura
Research Way2Wealth

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY23
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q1FY25
Concall Q1FY24
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY24
Presentation Q1FY21
Presentation Q1FY20

Company News

Fortis Healthcare Stock Price Analysis and Quick Research Report. Is Fortis Healthcare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Fortis Healthcare and its performance over the period of time. Fortis Healthcare stock price today is Rs 754.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Fortis Healthcare cash from the operating activity was Rs 218.4486 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Fortis Healthcare has a Debt to Equity ratio of 0.0347 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Fortis Healthcare , the EPS growth was 107.2404 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Fortis Healthcare has OPM of 16.3199040479151 % which is a good sign for profitability.
     
  • ROE: Fortis Healthcare have a poor ROE of 2.2099 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Fortis Healthcare is Rs 754. One can use valuation calculators of ticker to know if Fortis Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Fortis Healthcare
X